Promising new drug being evaluated as possible treatment option for fragile X syndrome
Wednesday, January 7, 2009 - 09:49
in Health & Medicine
A pilot trial of an oral drug therapy called fenobam has shown promising initial results and could be a potential new treatment option for adult patients with Fragile X syndrome (FXS). Findings of the open label, single-dose study by researchers at Rush University Medical Center and the University of California, Davis, Medical Center are to be published in the upcoming January issue of the Journal of Medical Genetics.